This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2000 Jan;30(1):234-5.

doi: 10.1086/313576.

Amoxicillin versus sparfloxacin in the treatment of presumed pneumococcal pneumonia

PMID: 10619776
DOI: 10.1086/313576

Comparative Study

Amoxicillin versus sparfloxacin in the treatment of presumed pneumococcal pneumonia

J R Johnson. Clin Infect Dis. 2000 Jan.

. 2000 Jan;30(1):234-5.

doi: 10.1086/313576.

Author

PMID: 10619776
DOI: 10.1086/313576

No abstract available

PubMed Disclaimer

Comment on

Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
Aubier M, Verster R, Regamey C, Geslin P, Vercken JB. Aubier M, et al. Clin Infect Dis. 1998 Jun;26(6):1312-20. doi: 10.1086/516366. Clin Infect Dis. 1998. PMID: 9636854 Clinical Trial.
A new fluoroquinolone for community-acquired pneumonia.
Young LS. Young LS. Clin Infect Dis. 1998 Jun;26(6):1322-3. doi: 10.1086/516367. Clin Infect Dis. 1998. PMID: 9636856 No abstract available.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems